Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Leonardo M.R. Ferreira and Mohammed A Mostajo-Radji
Additional contact information
Leonardo M.R. Ferreira: University of California, San Francisco

No cyqx8, SocArXiv from Center for Open Science

Abstract: Convalescent plasma therapy holds promise as a transient treatment for COVID-19. Yet, blood products are important sources of HIV infection in low- and middle-income nations. Great care must be taken to prevent plasma therapy from fueling HIV epidemics in the developing world.

Date: 2020-07-06
New Economics Papers: this item is included in nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://osf.io/download/5ee273f1a777b7000dab29ca/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:osf:socarx:cyqx8

DOI: 10.31219/osf.io/cyqx8

Access Statistics for this paper

More papers in SocArXiv from Center for Open Science
Bibliographic data for series maintained by OSF ().